USA flag logo/image

An Official Website of the United States Government

IMMUNOISOLATED CELL TRANSPLANTS FOR TREATMENT OF PARKINSON'S DISEASE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
13992
Program Year/Program:
1990 / SBIR
Agency Tracking Number:
13992
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Cellular Transplants Inc
4 Richmond Sq Providence, RI 02906
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1990
Title: IMMUNOISOLATED CELL TRANSPLANTS FOR TREATMENT OF PARKINSON'S DISEASE
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

STRIATAL TRANSPLANTATION OF NEUROTRANSMITTER CELLS, IMMUNOISOLATED WITHIN A PERMSELECTIVE POLYMER MEMBRANE CAPSULE, REPRESENTS A NOVEL APPROACH TO THE TREATMENT OF PARKINSON'S DISEASE. THE TECHNIQUE HAS HAD PROMISING RESULTS IN SEVERAL RODENT MODELS, AND PRIMATE STUDIES ARE UNDERWAY. THE OVERALL OBJECTIVE OF THIS RESEARCH IS TO COMPLETE THE DEVELOPMENTS NECESSARY FOR WIDESPREAD MEDICAL ACCEPTANCE OF IMMUNOISOLATED CELLULAR TRANSPLANTATION IN THE TREATMENT OF NEURAL DISEASES. ONE UNACHIEVED PREREQUISITE TO SUCH ACCEPTANCE IS UNEQUIVOCAL DEMONSTRATION OF CAPSULE INTEGRITY AND COMPLETE SEGREGATION OF THE FOREIGN MATERIAL FROM THE HOST. ACCORDINGLY, THE SPECIFIC OBJECTIVE OF THIS PROJECT IS TO DEVELOP AND VALIDATE AN IN VIVO ASSAY OF INDIVIDUAL CAPSULE INTEGRITY BASED UPON ANTIBODY-MEDIATED COMPLEMENT LYSIS OF ENCAPSULATED PC12 CELLS.

Principal Investigator:

Michael J Lysaght
4012723310

Business Contact:

Small Business Information at Submission:

Cellular Transplants Inc
4 Richmond Sq Providence, RI 02906

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No